Lead
Health officials say the United States is experiencing an unusually early and active influenza season as a new H3N2 subclade spreads. The CDC’s latest update, current through Dec. 13, estimates at least 4.6 million illnesses, more than 49,000 hospitalizations and about 1,900 deaths so far this season. Wastewater surveillance and hospital reports show sharp rises in many regions, and young children have been among the hardest hit. Public-health authorities warn that holiday gatherings risk moving infections from school-aged groups into older adults.
Key Takeaways
- The CDC estimates at least 4.6 million flu illnesses this season, resulting in more than 49,000 hospitalizations and roughly 1,900 deaths (data through Dec. 13).
- WastewaterSCAN data show a 390% nationwide rise in influenza A concentrations from November to December.
- Influenza A H3N2 is the dominant strain; H3N2 historically causes higher hospitalization and death rates among older adults.
- Flu activity is high or very high in 14 states plus New York City, Washington, D.C., and Puerto Rico; localized severe outcomes have occurred in states with low overall activity.
- Three pediatric flu deaths were recorded in CDC data through Dec. 13; additional state reports (e.g., North Carolina, Wisconsin) have noted recent child fatalities that may not yet be reflected in federal totals.
- There is an early uptick in antivirals demand—Tamiflu prescriptions are rising sooner than in past seasons, suggesting earlier and possibly longer activity.
- Vaccine makers and public-health officials note a modest antigenic drift in an H3N2 subclade (K), making vaccine effectiveness hard to predict but still offering protection against severe illness in many seasons.
Background
The U.S. flu season began earlier and with more intensity in many regions than typical. Seasonal influenza activity is tracked by multiple systems: clinical testing and reporting, hospitalization counts, death certificates, and novel wastewater-based surveillance programs run by academic partners. This season’s pattern reflects a convergence of signals: rising lab-confirmed cases, climbing hospital admissions in some pediatric and adult wards, and steep increases in influenza A detected in wastewater samples between November and December.
H3N2 has been the dominant circulating subtype; historically H3N2 seasons correlate with higher severity among older adults and more hospitalizations overall. Public-health agencies enter each season with imperfect information about vaccine match because influenza viruses continually mutate. Last season (2024–2025) was exceptionally severe for children, with 288 pediatric deaths reported, a total that matched a record set in the 2009–2010 H1N1 pandemic.
Main Event
Federal surveillance reported widespread elevated activity through Dec. 13. The CDC’s domestic influenza surveillance team identified sustained increases across multiple indicators, prompting alerts in states where hospital capacity and pediatric caseloads rose notably. Several health departments have issued local advisories and are coordinating with hospitals to manage surges. The CDC scheduled its next surveillance update for Dec. 30 to capture more recent state-level reports.
Wastewater monitoring—an increasingly used early-warning system—recorded a 390% increase in influenza A signal nationwide from November to December, according to WastewaterSCAN, an academic program run through Stanford in partnership with Emory. Program leaders say the trend has been steadily upward with no sign of plateau so far, and the data have helped identify community spread before large rises in clinical diagnoses in some areas.
Pediatric clinics and children’s hospitals report sharp rises in positive tests. One medical director described a doubling of confirmed in-facility cases in a single week and noted symptom variability: some children present with classic, severe influenza symptoms while others have milder but persistent illness that still prompts visits. Clinicians are watching for household transmission at holiday gatherings, which could move infections from children into older relatives who face higher risk of severe outcomes.
Analysis & Implications
The emergence of an H3N2 subclade (referred to in surveillance as subclade K) has changed the antigenic profile of circulating viruses enough to raise concern about vaccine match. Antigenic drift—small changes in the virus’s surface proteins—can reduce vaccine effectiveness for preventing illness but often leaves substantial protection against severe disease, hospitalization and death. Public-health officials therefore continue to recommend vaccination because even a partially matched vaccine can blunt severity and lower the chance of complications.
Early increases in antiviral prescriptions, particularly oseltamivir (Tamiflu), suggest clinicians are seeing patients sooner and prescribing treatment earlier than in past seasons. That pattern typically signals an early wave of clinical disease and can foreshadow longer overall activity. Wider antiviral use increases the need for clinicians to prioritize treatment for high-risk patients (young children, pregnant people, older adults, and those with chronic conditions) and to monitor antiviral supply chains.
Hospitals could face mixed burdens: pediatric wards have seen substantial caseloads in some regions, while H3N2’s tendency toward more severe outcomes in older adults may strain adult inpatient and ICU capacity if community spread reaches those groups. The holiday period—when families mix across age groups—heightens the risk that school-based transmission will seed infections in older household members, potentially increasing hospitalizations and fatalities among seniors.
Comparison & Data
| Metric | Value (season to Dec. 13) |
|---|---|
| Estimated illnesses | 4.6 million |
| Estimated hospitalizations | >49,000 |
| Estimated deaths | ~1,900 |
| Wastewater influenza A rise (Nov–Dec) | +390% |
| States with high/very high activity | 14 states + NYC, D.C., Puerto Rico |
Putting these figures in context, estimated illnesses and hospitalizations place this season among the earlier and more active starts observed in recent years. The wastewater percentage rise is a relative measure of concentration rather than a direct case count, but such steep increases have preceded clinical surges in multiple localities. State-level snapshots vary widely: some states report widespread high activity while others show low or minimal activity but still experience severe individual outcomes.
Reactions & Quotes
“Activity is higher than normal across several surveillance measures,”
Alicia Budd, CDC influenza surveillance lead (paraphrased)
Context: CDC leadership has emphasized the breadth of indicators showing elevated activity and scheduled regular updates to incorporate late reports from states.
“We are not seeing signs that these wastewater signals are leveling off,”
Marlene Wolfe, WastewaterSCAN program director (paraphrased)
Context: Wastewater researchers regard rising concentrations as an early warning that community transmission may continue to increase.
“Some children have very classic, severe influenza presentation, while others have milder symptoms but still require care,”
Dr. Chase Shutak, pediatric medical director (paraphrased)
Context: Clinicians report both typical and atypical presentations, complicating outpatient triage and testing patterns.
Unconfirmed
- Several state-reported pediatric deaths (e.g., recent reports from North Carolina and Wisconsin) may not yet be fully integrated into CDC national totals through Dec. 13.
- The precise vaccine effectiveness against the H3N2 subclade K this season remains uncertain until post-season analyses are completed.
- Whether the current wastewater and clinical upward trends will peak before widespread holiday mixing or continue through winter is not yet known.
Bottom Line
The U.S. is experiencing an early, geographically uneven and in places intense influenza season driven mainly by H3N2, with surveillance indicating rapid increases in community spread. Vaccination remains the primary preventive tool—public-health experts stress it can reduce severe outcomes even if the circulating virus has drifted—and clinicians are prioritizing antivirals for those at highest risk.
Because children are driving much of the current case volume, holiday gatherings may accelerate transmission to older adults who face higher risk of severe disease during H3N2 seasons. Individuals should consider vaccination if eligible, stay home when ill, and seek prompt medical evaluation for high-risk people to enable timely antiviral treatment.